Crowley John F
- SEC CIK
- 0001400973
No open-market purchases or sales filed in the past year.
Current role at each company
- FOLD Amicus Therapeutics, Inc.Executive Chairmanas of Mar 15, 2024
- NTLA Intellia Therapeutics, Inc.Directoras of Jun 16, 2023
- TRDA Entrada Therapeutics, Inc.Directoras of Jun 12, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Crowley John F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FOLD Amicus Therapeutics, Inc.
Executive Chairman57 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2021 (view filing) | Jul 12 | 2 days | Crowley John FChairman & CEO | SSale | −14.9K | $9.31 | −$138.6K | −1.7%862.3K after | |
| Aug 9, 2021 (view filing) | Aug 5 | 4 days | Crowley John FChairman & CEO | SSale | −37.0K | $10.03 | −$371.1K | −4.2%847.3K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Crowley John FChairman & CEO | SSale | −22.0K | $10.27 | −$225.9K | −2.5%847.3K after | |
| Sep 7, 2021 (view filing) | Sep 1 | 6 daysLate | Crowley John FChairman & CEO | SSale | −7.50K | $11.50 | −$86.3K | −0.9%839.8K after | |
| Sep 8, 2021 (view filing) | Sep 3 | 5 days | Crowley John FChairman & CEO | SSale | −5.24K | $12.02 | −$63.0K | −0.6%839.8K after | |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Crowley John FChairman & CEO | SSale | −22.0K | $11.08 | −$243.8K | −2.6%839.8K after | |
| Oct 4, 2021 (view filing) | Oct 1 | 3 days | Crowley John FChairman & CEO | SSale | −7.50K | $10.00 | −$75.0K | −0.9%832.3K after | |
| Oct 18, 2021 (view filing) | Oct 15 | 3 days | Crowley John FChairman & CEO | SSale | −22.0K | $11.22 | −$246.8K | −2.6%832.3K after | |
| Nov 3, 2021 (view filing) | Nov 1-3 | 2 days | Crowley John FChairman & CEO | SSale | −35.6K | $11.74 | −$417.3K | −4.1%824.5K after | 2 lots |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Crowley John FChairman & CEO | SSale | −24.9K | $11.75 | −$293.0K | −2.9%824.5K after |
TRDA Entrada Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2022 (view filing) | Jan 12 | 1 day | Crowley John FDirector | PPurchase | +5.00K | $9.72 | +$48.6K | New position5.00K after |
NTLA Intellia Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2021 (view filing) | Oct 5 | 2 days | Crowley John FDirector | SSale | −10.0K | $130.54 | −$1.31M | −82.7%2.09K after | 5 lots |
| Oct 13, 2021 (view filing) | Oct 11 | 2 days | Crowley John FDirector | SSale | −2.50K | $119.55 | −$298.9K | −54.4%2.09K after |